https://guy.alphagenics.co/blog/guy-climate-zone-ivb-drug-stability-insulin-glp1-cold-chain/Alphagenics Guyanaen2026-11-07Climate Zone IVb: why Guyana rejects drugs not made for its heathttps://guy.alphagenics.co/blog/guy-drug-import-permits-single-window-gafdd/Alphagenics Guyanaen2026-11-07Drug import permits in Guyana move online: the GA-FDD single windowhttps://guy.alphagenics.co/blog/guy-glp1-mounjaro-ozempic-guyana-oversight/Alphagenics Guyanaen2026-11-07Mounjaro and Ozempic in Guyana: President says demand outpaces ruleshttps://guy.alphagenics.co/blog/guy-insulin-glp1-public-sector-essential-medicines/Alphagenics Guyanaen2026-11-07Insulin to GLP-1 in Guyana's public system: what is coveredhttps://guy.alphagenics.co/blog/guy-medicine-shortages-mmu-dashboard-guyana/Alphagenics Guyanaen2026-11-07Medicine shortages in Guyana: Ali's dashboard and the 90 % promisehttps://guy.alphagenics.co/blog/guy-medicines-regulation-bill-pharmacovigilance-gafdd/Alphagenics Guyanaen2026-11-07Guyana's Medicines Regulation Bill and a new pharmacovigilance centrehttps://guy.alphagenics.co/blog/guy-ozempic-medical-spas-suitcase-trade-unregistered/Alphagenics Guyanaen2026-11-07Ozempic in Guyana's medical spas: the unregistered GLP-1 tradehttps://guy.alphagenics.co/blog/guy-peptide-guide-guyanese-physicians/Alphagenics Guyanaen2026-11-07Peptides in Guyana: a legal and evidence guide for physicianshttps://guy.alphagenics.co/blog/guy-retatrutide-unapproved-triple-agonist-guyana-law/Alphagenics Guyanaen2026-11-07Retatrutide in Guyana: a striking trial drug approved nowherehttps://guy.alphagenics.co/blog/guy-substandard-falsified-medicines-carpha-testing-registration/Alphagenics Guyanaen2026-11-07Substandard medicines in Guyana: 30 % failed testing, and the fixhttps://guy.alphagenics.co/blog/guy-tirzepatide-vs-semaglutide-trials-guyana-access/Alphagenics Guyanaen2026-11-07Tirzepatide vs semaglutide: head-to-head trials for Guyana doctors